Quotes by Les Funtleyder

“We figured there would be some deterioration, but not like this. It looks like problems across the board.”

“In terms of body language, management seemed a little more defensive to us than usual. Moreover, we find the lack of guidance from a company with the scale and savvy of Pfizer worrisome; it suggests to us that the company doesnt know itself about the future performance of its own internal operations.”

“Its not just the Cleveland Clinic.”

“When you start seeing these big, big products coming off patent, theres plenty for most of them to cut. It is quite possible that all of them have plenty more to cut if they want to.”

“For Pfizer, it offers some hope for the future that they can get novel products to market. This proves that they have drug development capability and points to a brighter future 18 months out.”

“The list is relatively short. There arent that many companies who could take it.”

“Theyre getting rid of unnecessary things and using the money to fund research and development.”

“It certainly will encourage more people to sue. This is going to be a decade-long process. Its probably going to make Merck reserve more money.”

“Getting larger really does matter. Scale helps because it helps drive greater discounts. The more enrollees you have, the better off you are in terms of costs.”

“At least we can measure whether the company is meeting its goals or not.”